KOMPAS.com- Between the performance of a number Covit-19 vaccine It is starting to be used to treat infections, and some have yet to be developed. However, one of them is being developed Australia Must be stopped.
Australia has announced a suspension Vaccine development Govt-19 announced Friday (11/12/2020) ABC Indonesia.
Vaccines are being developed by university researchers Queensland (UQ) and CSL should be stopped once a positive reaction is detected HIV In test takers.
In fact, the Australian government plans to buy 51 million doses of the Covid-19 vaccine.
With vaccine growth at a standstill, Australia is now waiting for vaccines from three producers in other countries.
Also read: The Moderna Covit-19 vaccine has been shown to provide immunity, at least within 3 months
In a statement, CSL Vaccine test Not to be outdone, they also emphasized that this vaccine is safe to believe.
Prior to testing, CSL expected cross-reactivity to occur, and they told participants whether a vaccine could interfere with certain HIV diagnostic tests.
Britain’s Professor Paul Young, who is leading vaccine development, said it would take at least another year to fix the problem.
The 11-month development of the Covit-19 vaccine to prevent coronavirus infection has disappointed many.
“But that’s science. Although this decision is very difficult, the urgent need for a vaccine must be a priority, “said Professor Young.
A researcher at the University of Queensland is working on the development of a Government-19 vaccine in March 2020.
Use clamp technology Molecule
At least 216 people participated in the trial of the vaccine developed by UQ and CSL.
In the experiment, the researchers found Corona antiviral drugs This results in additional antibodies that fail the HIV test, leading to a false positive result.
While the development of the corona virus vaccine by Pfizer / Bioendech and Moderna used messenger RNA technology, Australian scientists used molecular clamp technology.
The molecular clamp technology in the University of Queensland (UQ) vaccine uses two protein fragments found in HIV that bind vital fragments together. Virus SARS-CoV-2, Causes Govit-19 so that the immune system can learn to recognize it.
Also read: Australia’s first human trial of a coronavirus vaccine
So, Vaccine development technology This will allow the research team to speed up the vaccine development process.
Researchers have made sure that the vaccine they develop does not cause health problems and does not cause HIV infection.
Professor Young confirmed that the research team did not expect a ‘false positive’ reaction and that the molecular clamp technology used was safe and effective.
However, the decision to stop further development of the Covit-19 vaccine was taken by the Australian Government and CSL.
Description of the Covit-19 vaccine-
“We hoped that there could be a problem with the HIV protein, so we put it in the consent form for the participants,” said Professor Young.
However, he admitted that he did not expect all the participants to respond with such low antibodies to the test.
Meanwhile, Dr. CSL’s Russell Passer said the main idea of stopping the growth of vaccines was to build public trust.
“If no other vaccine is developed, we will survive. But the main problem is the reliance on this process, which makes it seem difficult to continue, “Dr. Passer explained.
Also read: Allergists warn of the Pfizer Govt-19 vaccine, and why?
After that, researchers at the University of Queensland will continue to research molecular clamp technology beyond the use of the two protein fragments found in HIV.
Australian Health Minister Greg Hunt is expected to halt EU vaccine development, given the possibility of withdrawal.
In addition, it is possible to increase the number of orders in all vaccine purchase agreements to combat current coronavirus infections.
Australian Prime Minister Scott Morrison’s cancellation of the Covit-19 vaccine trial has shown the public that governments and scientists are very cautious on this issue.
–
